Abstract
BackgroundData regarding the efficacy of directly administered antiretroviral therapy (DAART) are mixed. Opioid treatment programs (OTPs) provide a convenient framework for DAART. In a randomized controlled trial, we compared DAART and self-administered therapy (SAT) among HIV-infected subjects attending five OTPs in Baltimore, MD.MethodsHIV-infected individuals attending OTPs were eligible if they were not taking antiretroviral therapy (ART) or were virologically failing ART at last clinical assessment. In subjects assigned to DAART, we observed one ART dose per weekday at the OTP for up to 12 months. SAT subjects administered ART at home. The primary efficacy comparison was the between-arm difference in the average proportions with HIV RNA <50 copies/mL during the intervention phase (3-, 6-, and 12-month study visits), using a logistic regression model accounting for intra-person correlation due to repeated observations. Adherence was measured with electronic monitors in both arms.ResultsWe randomized 55 and 52 subjects from five Baltimore OTPs to DAART and SAT, respectively. The average proportions with HIV RNA <50 copies/mL during the intervention phase were 0.51 in DAART and 0.40 in SAT (difference 0.11, 95% CI: −0.020 to 0.24). There were no significant differences between arms in electronically-measured adherence, average CD4 cell increase from baseline, average change in log10 HIV RNA from baseline, opportunistic conditions, hospitalizations, mortality, or the development of new drug resistance mutations.ConclusionsIn this randomized trial, we found little evidence that DAART provided clinical benefits compared to SAT among HIV-infected subjects attending OTPs.Trial RegistrationClinicalTrails.gov NCT00279110 NCT00279110?term = NCT00279110&rank = 1
Highlights
Studies evaluating the efficacy of directly administered antiretroviral therapy (DAART) for the treatment of HIV-infected individuals have yielded mixed results
Based on promising results from a non-randomized pilot study [8], we conducted a for this trial and supporting CONSORT checklist are available as randomized trial to evaluate the efficacy of DAART in Opioid treatment programs (OTPs)
For the primary analysis and other binary outcomes, we evaluated the difference between arms using a logistic regression model with two explanatory variables: an indicator for follow-up versus baseline visits (X1 = 0 for baseline, X1 = 1 for visits at 3, 6, and 12 months), and an interaction term between the intervention indicator (X2 = 0 for self-administered therapy (SAT), X2 = 1 for DAART) and the follow-up indicator (X3 = X1*X2, which takes on the value of 1 for DAART on follow-up and 0 otherwise)
Summary
Studies evaluating the efficacy of directly administered antiretroviral therapy (DAART) for the treatment of HIV-infected individuals have yielded mixed results. Based on promising results from a non-randomized pilot study [8], we conducted a for this trial and supporting CONSORT checklist are available as randomized trial to evaluate the efficacy of DAART in OTPs. Data regarding the efficacy of directly administered antiretroviral therapy (DAART) are mixed. In a randomized controlled trial, we compared DAART and self-administered therapy (SAT) among HIV-infected subjects attending five OTPs in Baltimore, MD
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have